DNA-Dependent Cofactor Selectivity of the Glucocorticoid Receptor
The glucocorticoid receptor (GR) is one of the best-characterized steroid receptors and essential for the regulation of multiple physiological processes. Due to their multiple inhibitory effects on the immune system, glucocorticoids are especially suited for treatment of inflammations and autoimmune diseases, but prolonged therapy results in severe metabolic side effects due to alterations in glucose and lipid metabolism. Further side effects include osteoporosis, atrophy of the skin, myopathy, and psychosis. In the absence of its ligand, the GR is localized in the cytoplasm as part of a multiprotein complex composed of GR, heat-shock proteins, and immunophilins. Binding of glucocorticoids to the receptor induces release of GR from this complex and subsequent translocation to the nucleus. This leads to binding of receptor dimers to specific DNA motifs in the regulatory regions of target genes and to activation of their transcription (Beato et al. 1995; Mangelsdorf et al. 1995). The function of dimeric receptors is also influenced considerably by neighboring transcription factors (Leers et al. 1994; Burcin et al. 1997). The GR shows further types of action, which do not require the binding of receptor dimers to DNA-recognition sequences (Heck et al. 1994; Reichardt et al. 1998). Binding of the ligand to the receptor leads in most of these cases to repressed activity of genes which are activated through other transcription factors, for example during the immunogenic reaction. This transcriptional crosstalk with transcription factors like AP-1, NF-κB or Stat5 occurs without direct binding to DNA; presumably on the basis of protein-protein interactions with the DNA-bound transcription factors (Jonat et al. 1990; Lucibello et al. 1990; Yang-Yen et al. 1990; Schüle and Evans 1991; König et al. 1992; Stöcklin et al. 1996; Heck et al. 1997). In another crosstalk mechanism (the proliferin gene), the GR presumably binds as a monomer along with other transcription factors to a “half” recognition sequence in a “composite element” (Diamond et al. 1990). Furthermore, negative response elements (nGREs; nTREs) have been described for glucocorticoid and also thyroid hormone receptors (Drouin et al. 1993; Saatcioglu et al. 1994; Lefstin and Yamamoto 1998; Awad et al. 1999). The molecular mechanism of all of these forms of gene repression via GR remains unclear.
KeywordsEstrogen Osteoporosis Adenosine Immobilization Dexamethasone
Unable to display preview. Download preview PDF.
- Awad TA, Bigler J, Ulmer JE, Hu YJ, Moore JM, Lutz M, Neiman PE, Collins SJ, Renkawitz R, Lobanenkov VV, Filippova GN (1999) Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J Biol Chem 274: 27092–27098PubMedCrossRefGoogle Scholar
- Baniahmad A, Thormeyer D, Renkawitz R (1997) tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors. Mol Cell Biol 17: 4259–4271Google Scholar
- Burcin M, Arnold R, Lutz M, Kaiser B, Runge D, Lottspeich F, Filippova GN, Lobanenkov VV, Renkawitz R (1997) Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol 17: 1281–1288PubMedGoogle Scholar
- Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43–48PubMedCrossRefGoogle Scholar
- Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 ( Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189–1204Google Scholar
- Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy ML, Eisman JA (1989) 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246: 1158–1161Google Scholar
- Poliard A, Bakkali L, Poiret M, Foiret D, Danan JL (1990) Regulation of the rat alpha-fetoprotein gene expression in liver. Both the promoter region and an enhancer element are liver-specific and negatively modulated by dexamethasone. J Biol Chem 265: 2137–2141Google Scholar
- Schiile R, Evans RM (1991) Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet 7: 377–381Google Scholar